Loading…
Differential sensitivity of human papillomavirus type 16+ and type 18+ cervical carcinoma cells to CD95‐mediated apoptosis
When cervical carcinoma cells were monitored for apoptotic signals, HPV18+ lines were found to be highly sensitive to agonistic CD95 antibodies or recombinant CD95 ligands after co‐exposure with CHX (CD95S). In contrast, HPV16+ cervical carcinoma cells and HPV16‐immortalized non‐malignant human kera...
Saved in:
Published in: | International journal of cancer 2001-09, Vol.93 (6), p.823-831 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | When cervical carcinoma cells were monitored for apoptotic signals, HPV18+ lines were found to be highly sensitive to agonistic CD95 antibodies or recombinant CD95 ligands after co‐exposure with CHX (CD95S). In contrast, HPV16+ cervical carcinoma cells and HPV16‐immortalized non‐malignant human keratinocytes were CD95‐resistant (CD95R) under equivalent conditions. Somatic cell hybridization between CD95S and CD95R cervical carcinoma cell lines revealed that CD95 sensitivity was a dominant trait, which could be correlated with abundant c‐Myc and low Bcl‐XL expression. Although CD95R cervical carcinoma cells expressed even higher levels of p53 and CD95 receptor at the surface, resistance could be attributed to the inability to form a functional DISC, necessary for successful transmission of the apoptogenic response. These data indicate that resistance to apoptotic stimuli represents an important immunological escape mechanism during virus‐induced carcinogenesis. © 2001 Wiley‐Liss, Inc. |
---|---|
ISSN: | 0020-7136 1097-0215 |
DOI: | 10.1002/ijc.1405 |